Sickle Cell Header

Dashed Line

Agenda | Speakers

Dashed Line

AGENDA

AUGUST 27, 2008

1:00 PM - 1:05 PM

Overview
Gregory J. Kato, MD

1:05 PM - 1:10 PM

Welcome
Henrietta D. Hyatt-Knorr, MA, Office of Rare Diseases

Session1

DISRUPTED NITRIC OXIDE METABOLISM AND OXIDATIVE STRESS
Chairs: Constance Tom Noguchi, PhD and Jeffery L. Miller, MD

1:10 PM - 1:40 PM

Oxidation, Hemostatic Activation and Adhesion
Robert P. Hebbel, MD

1:40 PM - 2:10 PM

Nitric Oxide Scavenging by Cell-Free Plasma Hemoglobin
Mark T. Gladwin, MD

2:10 PM - 2:40 PM

Catalytic Nitric Oxide Scavenging by Oxidases and Oxygenases
Bruce Freeman, PhD

2:40 PM - 3:00 PM

BREAK

Session 2

VASCULAR DYSFUNCTION AND CELL ADHESION
Chairs: Robert P. Hebbel, MD and Marie J. Stuart, MD

3:00 PM - 3:30 PM

Nitric oxide resistance in the sickle cell mouse
Dhananjay K. Kaul, PhD

3:30 PM - 4:00 PM

Mediators of cell adhesion in sickle cell disease
Paul S. Frenette, MD

4:00 PM - 4:30 PM

Endothelial dysfunction in the sickle cell mouse
Cheryl A. Hillery, MD

4:30 PM - 5:00 PM

Glutathione dysregulation in sickle cell disease
Claudia R. Morris, MD

5:00 PM - 6:30 PM

Poster Session (Attended reception)

AUGUST 28, 2008

Session 3

HEMOSTATIC ACTIVATION AND GENOMICS OF VASCULOPATHY
Chairs: James G. Taylor, VI, MD and Mary E. Fabry, PhD

8:00 AM - 8:30 AM

Hemostatic activation in sickle cell disease
Kenneth I. Ataga, MD

 

OTHER VASCULOPATHIES

8:30 AM - 9:00 AM

Hemolytic rate and risk of stroke in children with sickle cell disease
Françoise Bernaudin, MD

9:00 AM - 9:30 AM

Low nitric oxide bioactivity and priapism
Hunter C. Champion, MD, PhD

 

GENOMICS OF VASCULAR COMPLICATIONS

9:30 AM - 10:00 AM

Genomic markers of sickle cell priapism and leg ulcers
Martin H. Steinberg, MD

10:00 AM - 10:30 AM

Genomic markers of sickle cell pulmonary hypertension
Marilyn J. Telen, MD

10:30 AM - 10:50 AM

BREAK

Session 4

TRANSLATIONAL THERAPEUTICS
Chairs: John Fitzgerald Tisdale, MD and Lewis L. Hsu, MD, PhD

10:50 AM - 11:20 AM

Vascular targets for small molecule therapeutics
Gregory J. Kato, MD

11:20 AM - 11:50 AM

Cellular approaches for gene therapy for sickle cell disease
Tim M. Townes, PhD

11:50 AM - 1:20 PM

Poster Session and lunch

Session 5

ATHEROSCLEROSIS: PARALLELS WITH SICKLE VASCULOPATHY?
Chairs: Gregory J. Kato, MD and Gregory M. Vercellotti, MD

1:20 PM - 1:50 PM

The role of hypertriglyceridemia in atherosclerosis
Anh Le, PhD

1:50 PM - 2:20 PM

Apolipoproteins in sickle cell vasculopathy
Kirkwood A. Pritchard, Jr., PhD

2:20 PM - 2:50 PM

 

Systolic hypertension in vasculopathy: Lessons from the
Framingham heart study
Daniel Levy, MD

2:50 PM - 3:20 PM

NOS uncoupling in vascular disease
David A. Kass, MD

3:20 PM - 3:40 PM

Closing Remarks

3:40 PM - 4:00 PM

BREAK

4:00 PM - 6:00 PM

Topics for Future Research